Gulfem Guler

Vice President, Translational Research Clear Note Health

Thursday 25th September 2025

Empowering Drug Development with Epigenomic Liquid Biopsy Technologies

9:30 am

5hmC is an epigenetic mark that is associated with active genes and regulatory regions that are cell type- and disease-specific, making it highly suitable for oncology biomarker applications
Virtuoso epigenomic platform provides genome-wide 5hmC profiles to unlock unique insights into transcriptionally active biological programs from plasma samples
Virtuoso-powered applications include cancer early detection, identification of tissue of origin, predictive and prognostic biomarkers, and disease monitoring